Table 1.
Group | Let-7a |
miR-124 |
miR-125a-5p |
miR-132 |
GAPDH mRNA |
|||||
---|---|---|---|---|---|---|---|---|---|---|
Cta | Fold-change compared to shamb | Ct | Fold-change compared to sham | Ct | Fold-change compared to sham | Ct | Fold-change compared to sham | Ct | Fold-change compared to sham | |
Saline-treated N = 14 | 21.98 ± 0.52 | 1.00 | 21.53 ± 0.45 | 1.00 | 22.61 ± 0.84 | 1.00 | 20.94 ± 0.44 | 1.00 | 18.51 ± 0.39 | 1.00 |
Enoxacin (10 mg/kg) N = 12 | 18.39 ± 1.74 | 12.34 | 19.54 ± 1.5 | 4.08 | 19.28 ± 2.05 | 10.38 | 19.43 ± 1.06 | 2.92 | 18.55 ± 0.42 | 0.97 |
(p = 6.9 × 10−8) | (p = 0.000038) | (p = 0.0000048) | (p = 0.000046) | |||||||
Enoxacin (25 mg/kg) N = 12 | 17.84 ± 0.91 | 17.90 | 18.99 ± 2.68 | 5.93 | 18.1 ± 1.09 | 22.33 | 18.81 ± 0.71 | 4.46 | 18.54 ± 0.34 | 0.98 |
(p = 1.2 × 10−13) | (p = 0.00091) | (p = 8.9 × 10−12) | (p = 0.00002) |
a Indicated are means ± SD of Ct values in each group. Note that Ct values follow a log2 scale (i.e., a difference in Ct values of 1 means a twofold change in abundance);
b sham (no shock) groups were treated with saline or with enoxacin 10 or 25 mg/kg for 1 week; t-test p values are in parentheses.